Insider Trading & Ownership of TAKEDA PHARMACEUTICAL CO LTD

Location
Tokyo, Japan
Summary
The estimated value of insider holdings of TAKEDA PHARMACEUTICAL CO LTD is at least $121,288,868 dollars as of 09 Dec 2025. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $71.54M. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $30.42M. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Ovid Therapeutics Inc. and owns shares of Ovid Therapeutics Inc. (OVID) stock worth about $13.17M. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Theseus Pharmaceuticals, Inc. and owns shares of Theseus Pharmaceuticals, Inc. stock worth about $4.93M. TAKEDA PHARMACEUTICAL CO LTD is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $1.22M.
Signature
/s/ Max Heuer, Authorized Signatory, Takeda Pharmaceutical Company Limited
All Insider Reports
All Insider Reports

Notify me when TAKEDA PHARMACEUTICAL CO LTD files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of TAKEDA PHARMACEUTICAL CO LTD

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DAWN Day One Biopharmaceuticals, Inc. 10%+ Owner $71,544,250 07 Dec 2021
PHAT Phathom Pharmaceuticals, Inc. 10%+ Owner $30,420,222 24 Jan 2024
OVID Ovid Therapeutics Inc. 10%+ Owner $13,172,994 08 Dec 2025
THRX Theseus Pharmaceuticals, Inc. 10%+ Owner $4,927,052 12 Oct 2021
XLO Xilio Therapeutics, Inc. 10%+ Owner $1,224,350 26 Oct 2021
HLVX HilleVax, Inc. 10%+ Owner $0 17 Sep 2025
CALA Calithera Biosciences, Inc. Former 10% Owner 17 Apr 2023

Insider Transactions Reported by TAKEDA PHARMACEUTICAL CO LTD:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.